<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00864383</url>
  </required_header>
  <id_info>
    <org_study_id>REMoxTB</org_study_id>
    <secondary_id>ISRCTN85595810</secondary_id>
    <nct_id>NCT00864383</nct_id>
  </id_info>
  <brief_title>Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis</brief_title>
  <acronym>REMoxTB</acronym>
  <official_title>A Randomised Placebo - Controlled Double Blind Trial Comparing 1) a Two Month Intensive Phase of Ethambutol, Moxifloxacin, Rifampicin, Pyrazinamide Versus the Standard Regimen (Ethambutol, Isoniazid, Rifampicin, Pyrazinamide) and 2) a Treatment Shortening Regimen Comparing Two Months Moxifloxacin, Isoniazid, Rifampicin, Pyrazinamide Followed by Two Months Moxifloxacin, Isoniazid, Rifampicin Versus the Standard Regimen (Two Months Ethambutol, Isoniazid, Rifampicin, Pyrazinamide Followed by Four Months Isoniazid and Rifampicin) for the Treatment of Adults With Pulmonary Tuberculosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Global Alliance for TB Drug Development</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European and Developing Countries Clinical Trials Partnership (EDCTP)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Global Alliance for TB Drug Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      REMoxTB is a study for the &quot;Rapid Evaluation of Moxifloxacin in the treatment of sputum smear
      positive tuberculosis&quot;. REMoxTB aims to find and evaluate new drugs and regimens that shorten
      the duration of tuberculosis therapy.

      The purpose of REMoxTB is to evaluate the efficacy, safety and acceptability of two
      moxifloxacin-containing treatment combinations to determine whether substituting ethambutol
      with moxifloxacin in one combination, and/or substituting isoniazid with moxifloxacin in
      another combination, makes it possible to reduce the duration of treatment for TB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current recommended treatments for tuberculosis (TB) require a patient to take multiple
      drugs for six to eight months. Because the course of therapy is long, many patients do not
      adhere to treatment and as a consequence they have a poor outcome. In these cases either the
      sputum is not cleared of the bacteria causing tuberculosis, or the disease returns again
      (called relapse). Response to medication can be monitored during treatment by collecting
      regular sputum samples and examining these samples by culture, for the organisms that cause
      tuberculosis.

      The commonly used drugs to treat tuberculosis are rifampicin, isoniazid, ethambutol and
      pyrazinamide. Previous studies in animals and in humans suggest that a new drug called
      moxifloxacin may also be an effective treatment in tuberculosis. Moreover, promising
      laboratory studies on mice suggest that moxifloxacin may enable the total duration of
      chemotherapy to be reduced to four months, which would be a significant improvement for
      patients taking medication for tuberculosis.

      This study will involve comparisons that are designed to assess whether substituting
      moxifloxacin for individual drugs in existing treatment combinations will enable tuberculosis
      treatment to be shortened. Patients selected for the study will be allocated to one of three
      treatment groups. The first group will be given six months standard treatment. A second group
      will receive moxifloxacin substituted for ethambutol, as part of a four month regimen, to see
      whether the shorter treatment is not inferior to the standard six month treatment. The third
      group will receive moxifloxacin substituted for isoniazid, as part of a four month regimen,
      to see whether the shorter treatment is not inferior to the standard six month treatment.

      Hypotheses:

        1. In treatment-naïve adults with active pulmonary TB treated with eight weeks of
           moxifloxacin (M), isoniazid (H), rifampicin (R) and pyrazinamide (Z) (i.e. a standard
           regimen where moxifloxacin is substituted for ethambutol (E)), followed by nine weeks of
           moxifloxacin, isoniazid and rifampicin, followed by nine weeks of placebo, the
           proportion of patients who experience treatment failure or disease relapse in the twelve
           months following treatment completion will not be inferior to that observed in patients
           who are treated with a standard regimen (eight weeks of ethambutol, isoniazid,
           rifampicin and pyrazinamide followed by eighteen weeks of isoniazid plus rifampicin)
           (Comparison 1).

        2. In treatment-naïve adults with active pulmonary TB treated with eight weeks of
           ethambutol, moxifloxacin, rifampicin and pyrazinamide (i.e. a standard regimen where
           moxifloxacin is substituted for isoniazid), followed by nine weeks of moxifloxacin and
           rifampicin followed by nine weeks of placebo, the proportion of patients who experience
           treatment failure or disease relapse in the twelve months following treatment completion
           will not be inferior to that observed in patients who are treated with a standard
           regimen (eight weeks of ethambutol, isoniazid, rifampicin and pyrazinamide followed by
           eighteen weeks of isoniazid plus rifampicin) (Comparison 2).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combined Failure of Bacteriological Cure and Relapse Within One Year of Completion of Therapy as Defined by Culture Using Solid Media (Lowenstein-Jensen - LJ).</measure>
    <time_frame>18 months (within one year of completion of therapy)</time_frame>
    <description>The primary efficacy outcome was the proportion of patients who had bacteriologically or clinically defined failure or relapse within 18 months after randomization (a composite unfavorable outcome). Culture-negative status was defined as two negative-culture results at different visits without an intervening positive result. The date of culture-negative status was defined as the date of the first negative-culture result. This status continued until there were two positive cultures, without an intervening negative culture, or until there was a single positive culture that was not followed by two negative cultures. Relapse strains were those shown to be identical on 24-locus Mycobacterial interspersed repetitive units (MIRU) analysis. For the final 18 month study visit when both L-J samples were contaminated or missing, if the subject could not be brought back, liquid medium culture results were used in place of solid medium culture results.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patients With Grade 3 or 4 Adverse Events (Using a Modified Division of Acquired Immunodeficiency Syndrome National Institute of Allergy and Infectious Diseases [DAIDS] Scale of Adverse Event Reporting)</measure>
    <time_frame>18 months (within one year of completion of therapy)</time_frame>
    <description>The number of participants includes all patients who had at least one grade 3 or 4 adverse event.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Combined Failure of Bacteriological Cure and Relapse as Defined by Culture Using Liquid Media (Mycobacteria Growth Indicator Tube-MGIT).</measure>
    <time_frame>18 months (within one year of completion of therapy)</time_frame>
    <description>The secondary analysis of efficacy outcome was the proportion of patients who had bacteriologically or clinically defined failure or relapse within 18 months after randomization (a composite unfavorable outcome) based on MGIT. Culture-negative status was defined as two negative-culture results at different visits without an intervening positive result. The date of culture-negative status was defined as the date of the first negative-culture result. This status continued until there were two positive cultures, without an intervening negative culture, or until there was a single positive culture that was not followed by two negative cultures. Relapse strains were those shown to be identical on 24-locus Mycobacterial interspersed repetitive units (MIRU) analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Who Are Culture Negative (Solid LJ Culture)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Number of patients who are TB LJ culture negative at 8 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Who Are Culture Negative (Liquid MGIT Culture)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Number of patients who are TB MGIT culture negative at 8 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Culture Negative Sputum Sample (LJ Solid Media)</measure>
    <time_frame>18 months</time_frame>
    <description>Culture negative for TB using LJ cultures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Culture Negative Sputum Sample (MGIT Liquid Media)</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity Analysis Assuming All Losses to Follow-up and Non-tuberculous Deaths Have an Unfavorable Outcome Using Solid (L-J) Media.</measure>
    <time_frame>18 months</time_frame>
    <description>Sensitivity Analysis of Primary Efficacy Results of All Randomized Subjects Imputing Unfavorable for Missing Outcomes. Analysis is the number of subjects with an unfavorable outcome. Favorable outcome is defined as the number of subjects with a negative TB culture status at 18 months (at or after 72 weeks), who had not already been classified as having an unfavorable outcome, and whose last positive TB culture result (&quot;isolated positive culture&quot;) was followed by at least two negative culture results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity Analyses Assuming All Losses to Follow-up and Non-tuberculous Deaths Have a Favourable Outcome Using Solid (L-J) Media.</measure>
    <time_frame>18 months</time_frame>
    <description>Sensitivity Analysis of Primary Efficacy Results of All Randomized Subjects Imputing Favorable for Missing Outcomes. Analysis is the number of subjects with an unfavorable outcome. Favorable outcome is defined as the number of subjects with a negative TB culture status at 18 months (at or after 72 weeks), who had not already been classified as having an unfavorable outcome, and whose last positive TB culture result (&quot;isolated positive culture&quot;) was followed by at least two negative culture results.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1931</enrollment>
  <condition>Pulmonary Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Regimen 1 - 2EHRZ/4HR (control regimen)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regimen 2 - 2MHRZ/2MHR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regimen 3 - 2EMRZ/2MR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin</intervention_name>
    <description>Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
    <arm_group_label>Regimen 1 - 2EHRZ/4HR (control regimen)</arm_group_label>
    <arm_group_label>Regimen 2 - 2MHRZ/2MHR</arm_group_label>
    <arm_group_label>Regimen 3 - 2EMRZ/2MR</arm_group_label>
    <other_name>Avelox</other_name>
    <other_name>Avelon</other_name>
    <other_name>Avalox</other_name>
    <other_name>Myambutol</other_name>
    <other_name>Nydrazid</other_name>
    <other_name>Rifampin</other_name>
    <other_name>Rifadin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed written consent or witnessed oral consent in the case of illiteracy, before
             undertaking any trial related activity.

          -  Two sputum specimens positive for tubercle bacilli on smear microscopy at least one of
             which must be processed and positive at the study laboratory.

          -  Aged 18 years or over.

          -  No previous anti-tuberculosis chemotherapy.

          -  A firm home address that is readily accessible for visiting and willingness to inform
             the study team of any change of address during the treatment and follow-up period.

          -  Agreement to participate in the study and to give a sample of blood for HIV testing
             (see appendices 1 &amp; 2).

          -  Pre-menopausal women must be using a barrier form of contraception or be surgically
             sterilised or have an IUCD in place.

          -  Laboratory parameters performed up to 14 days before enrolment.

               -  Serum aspartate transaminase (AST) and alanine transaminase (ALT) activity less
                  than 3 times the upper limit of normal.

               -  Serum total bilirubin level less than 2.5 times upper limit of normal. Creatinine
                  clearance (CrCl) level greater than 30 mls/min.

               -  Haemoglobin level of at least 7.0 g/dL.

               -  Platelet count of at least 50x109cells/L.

               -  Serum potassium greater than 3.5 mmol/L.

          -  Negative pregnancy test (women of childbearing potential).

        Exclusion Criteria:

          -  Unable to take oral medication.

          -  Previously enrolled in this study.

          -  Received any investigational drug in the past 3 months.

          -  Received an antibiotic active against M. tuberculosis in the last 14 days
             (fluoroquinolones, macrolides, standard anti-tuberculosis drugs).

          -  Any condition that may prove fatal during the first two months of the study period.

          -  TB meningitis or other forms of severe tuberculosis with high risk of a poor outcome

          -  Pre-existing non-tuberculosis disease e.g. diabetes, liver or kidney disease, blood
             disorders,peripheral neuritis, chronic diarrhoeal disease in which the current
             clinical condition of the patient is likely to prejudice the response to, or
             assessment of treatment.

          -  Pregnant or breast feeding.

          -  Suffering from a condition likely to lead to uncooperative behaviour e.g. psychiatric
             illness or alcoholism.

          -  Contraindications to any medications in the study regimens.

          -  Known to have congenital or sporadic syndromes of QTc prolongation or receiving
             concomitant medication reported to increase the QTc interval (e.g. amiodarone,
             sotalol, disopyramide, quinidine, procainamide, terfenadine).

          -  Known allergy to any fluoroquinolone antibiotic or history of tendinopathy associated
             with quinolones.

          -  Patients already receiving anti-retroviral therapy.

          -  Patients whose initial isolate is shown to be multiple drug resistant (i.e. resistant
             to rifampicin and isoniazid) or monoresistant to rifampicin, or resistant to any
             fluoroquinolone)

          -  Weight less than 35kg

          -  HIV infection with CD4 count less than 250 cells/µL.

          -  End stage liver failure (class Child-Pugh C).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen H Gillespie, MB BCh BAO MD DSc</last_name>
    <role>Study Director</role>
    <affiliation>University of St Andrews</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew Nunn, BSc MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>MRC Clinical Trials Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sarah K Meredith, MB BS MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>MRC Clinical Trials Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timothy D McHugh, BSc PhD CSi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Medical Microbiology, Royal Free and University College Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ali Zumla, BSc MBChB MSc PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for International Health, Royal Free and University College Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Pym, MB BMRCP PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unit for Clinical &amp; Biomedical TB Research, MRC Durban</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Mwaba, MB ChB MMed PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Teaching Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Noel Sam, MMed MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kilimanjaro Christian Medical Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andreas Diacon, BM MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tiervlei Trial Center and University of Stellenbosch</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rodney Dawson, MB ChB FCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for TB Research and Innovation, UCT Lung Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Evans Amukoye, MBChB. Mmed (Paediatric)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Respiratory Disease Research at KEMRI</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leonard Maboko, MD MSc PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NIMR - Mbeya Medical Research Programme</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ian Sanne, MBBCH FCP(SA)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical HIV Research Unit (CHRU), Westdene</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cheryl Louw, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Madibeng Centre For Research, Brits</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mengqui Gao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tuberculosis and Thoracic Tumor Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qing Zhang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Pulmonary Hospital, Shanghai, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiexiu Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TB Institute, Tianjin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aziah Mahayiddin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Respiratory Medicine (IPR) Jalan Pahang, Malaysia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Watchara Boonsawat, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Srinagarind Hospital, Division of Pulmonary Medicine, Khon Kaen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charoen Chuchottaworn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chest Disease Institute (CDI), Ministry of Public Health, Nonthaburi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pairaj Kateruttanakul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rajavithi Hospital, Division of Pulmonary, Department of Medicine, Bangkok</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerardo Amaya-Tapia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de occidente de la secretaria, Seattle, Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen Murray, M.D, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Global Alliance for TB Drug Development</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Brown, BA, BM, BCh, MRCP, PhD, DTM&amp;H</last_name>
    <role>Principal Investigator</role>
    <affiliation>London School of Hygiene and Tropical Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rakesh Lal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Advanced Lung and Sleep Disorders, New Delhi, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rakesh Mittal, MBBS MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Mittal's Clinic, Balaji Medical Store, New Delhi, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A K Jain, MBBS FICA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diligent Hospital, New Delhi, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahesh Kapoor, MBBS DTCD</last_name>
    <role>Principal Investigator</role>
    <affiliation>A One Hospital, New Delhi, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>D K Chauhan, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr D.K. Chauhan, New Delhi, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahip Saluja, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Mahip Saluja Clinic, Meerut, U.P. India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neeraj Gupta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Neeraj Gupta, Firozabad ,U.P, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Subodh Katiyar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr Subodh, Swaroop Nagar,Kanpur, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nirmal K Jain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr.Nirmal Kumar Jain, Jaipur, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Komal Gupta, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kilkari , Lucknow , India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fahad Khan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New City Hospital and Trauma Centre, Lucknow, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vaibhav Gupta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saanvi MultiSpeciality Clinic, Moradabad, UP, India,</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suraj P Sondhi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. S. P. Sondhi Clinic , Meerut U.P India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Siddharth Agarwal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Siddharth Nursing Home, Agra, U.P India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sanjay Teotia, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Sanjay Teotia Clinic, Meerut, U.P , India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>S PS Chauhan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. SPS Chauhan, Firozabad, U.P-India,</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahesh Mishra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahatma Gandhi Medical College&amp; Hospital , Jaipur, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ashish Rohatgi, DTCD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ish Medical Centre and Respiratory Lab, New Delhi- India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Om P Rai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guru Tej Bahadur Hospital, Kanpur India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pawan Varshneya, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Varshneya Chest Clinic &amp; Eye Care Centre, Aligarh, UP India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>R K Garg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. R. K. Garg's Clinic, U.P, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vinod K Karhana, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prakash Devi Memorial Medical Centre,New Delhi, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vijay K Khurana, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ram-Tej Hospital, Agra, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Surya Kant, MD, FCCP, FNCP, FCAI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr.Surya Kant, Lucknow, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shalini Arya, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arya Chest Clinic, Meerut, UP,India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ashok K Singh, MD, FCCP, FCCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pulmonary Care and Sleep Clinic, Kanpur, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bhanu P Singh, MD, FCCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Surya Chest Foundation, Lucknow India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chandra P Singh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jigyasa Medical Center,Uttar Pradesh, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arun Aggarwal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indra Nursing Home and Maternity Centre, Uttar Pradesh, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anjula Bhargava, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rajul Nursing Home, Sasni Gate, Aligarh, UP India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angela Crook</last_name>
    <role>Principal Investigator</role>
    <affiliation>MRC Clinical Trials Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salome Charalambous</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Aurum Institute, Tembisa Hospital, South Africa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lerato Mohapi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soweto Perinatal HIV Research Unit, Johannesburg, South Africa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nesri Padayatchi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Caprisa eThakwini Research Facility, Durban, South Africa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sandy Pillay</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Clinical Trials Unit, Durban, South Africa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beijing Tuberculosis and Thoracic Tumor Research Institute</name>
      <address>
        <city>Beijing</city>
        <zip>101149</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Pulmonary Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TB Institute</name>
      <address>
        <city>Tianjin</city>
        <zip>300041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nirmal Kumar Jain</name>
      <address>
        <city>Jaipur</city>
        <state>Rajasthan</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mahatma Gandhi Medical College&amp; Hospital</name>
      <address>
        <city>Jaipur</city>
        <state>Rajsthan</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ram-Tej Hospital,</name>
      <address>
        <city>Agra</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Siddharth Nursing Home,</name>
      <address>
        <city>Agra</city>
        <state>Uttar pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rajul Nursing Home</name>
      <address>
        <city>Aligarh</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Varshneya Chest Clinic &amp; Eye Care Centre</name>
      <address>
        <city>Aligarh</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Neeraj Gupta Clinic</name>
      <address>
        <city>Firozabad</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>S.P.S Chauhan Clinic</name>
      <address>
        <city>Firozabad</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. R. K. Garg's Clinic,</name>
      <address>
        <city>Gaziabad</city>
        <state>Uttar Pradesh</state>
        <zip>2011002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indra Nursing Home and Maternity Centre</name>
      <address>
        <city>Ghaziabad</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. AK Singh Clinic</name>
      <address>
        <city>Kanpur</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. S. K. Katiyar, Swaroop Nagar,</name>
      <address>
        <city>Kanpur</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guru Tej Bahadur Hospital</name>
      <address>
        <city>Kanpur</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Komal Gupta</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New City Hospital and Trauma Centre,</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surya Chest Foundation,</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surya Kant Clinic</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Mahip Saluja Clinic, U.P.</name>
      <address>
        <city>Meerut,</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arya Chest Clinic, UP,India</name>
      <address>
        <city>Meerut</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. S. P. Sondhi Clinic,</name>
      <address>
        <city>Meerut</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sri Ram Plaza</name>
      <address>
        <city>Meerut</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jigyasa Medical Center</name>
      <address>
        <city>Moradabad</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saanvi MultiSpeciality Clinic,</name>
      <address>
        <city>Moradabad</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A-One Hospital</name>
      <address>
        <city>Delhi</city>
        <zip>110087</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. D.K. Chauhan</name>
      <address>
        <city>New Delhi</city>
        <zip>110002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre for advanced lung and sleep disorders</name>
      <address>
        <city>New Delhi</city>
        <zip>110026</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Mittal's clinic</name>
      <address>
        <city>New Delhi</city>
        <zip>110043</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diligent Hospital</name>
      <address>
        <city>New Delhi</city>
        <zip>110062</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ish Medical Centre and Respiratory Lab,</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Smt Prakash Devi Memorial Medical Centre,</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre for Respiratory Disease Research at KEMRI</name>
      <address>
        <city>Nairobi</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Respiratory Medicine (IPR) Jalan Pahang</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>53000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General de Occidente de la secretaria</name>
      <address>
        <city>Guadalajara</city>
        <state>Seattle</state>
        <zip>45170</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Madibeng centre for Research, 40 Pienaar Street,</name>
      <address>
        <city>Madibeng</city>
        <state>Brits</state>
        <zip>0250</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical HIV Research Unit (CHRU)</name>
      <address>
        <city>Johannesburg</city>
        <state>Westdene</state>
        <zip>2092</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre for TB Research and Innovation, University of Cape Town Lung Institute</name>
      <address>
        <city>Cape Town</city>
        <zip>7700</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tiervlei Trial Center and University of Stellenbosch</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unit for Clinical &amp; Biomedical TB Research, MRC Durban</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NIMR Mbeya Medical Research Programme</name>
      <address>
        <city>Mbeya</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kilimanjaro Christian Medical Centre</name>
      <address>
        <city>Moshi</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Srinagarind Hospital, Division of Pulmonary Medicine, Khon Kaen University</name>
      <address>
        <city>Khon Kaen</city>
        <state>Mueang</state>
        <zip>40200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chest Disease Institute (CDI), Ministry of Public,</name>
      <address>
        <city>Nonthaburi</city>
        <state>Mueang</state>
        <zip>11000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rajavithi Hospital, Division Of Pulmonary Medicine</name>
      <address>
        <city>Bangkok</city>
        <state>Phayathai</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Teaching Hospital</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
    <country>India</country>
    <country>Kenya</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>South Africa</country>
    <country>Tanzania</country>
    <country>Thailand</country>
    <country>Zambia</country>
  </location_countries>
  <reference>
    <citation>Bryant JM, Harris SR, Parkhill J, Dawson R, Diacon AH, van Helden P, Pym A, Mahayiddin AA, Chuchottaworn C, Sanne IM, Louw C, Boeree MJ, Hoelscher M, McHugh TD, Bateson AL, Hunt RD, Mwaigwisya S, Wright L, Gillespie SH, Bentley SD. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med. 2013 Dec;1(10):786-92. doi: 10.1016/S2213-2600(13)70231-5. Epub 2013 Nov 21.</citation>
    <PMID>24461758</PMID>
  </reference>
  <reference>
    <citation>Friedrich SO, Rachow A, Saathoff E, Singh K, Mangu CD, Dawson R, Phillips PP, Venter A, Bateson A, Boehme CC, Heinrich N, Hunt RD, Boeree MJ, Zumla A, McHugh TD, Gillespie SH, Diacon AH, Hoelscher M; Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics (PanACEA). Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med. 2013 Aug;1(6):462-70. doi: 10.1016/S2213-2600(13)70119-X. Epub 2013 Jul 1.</citation>
    <PMID>24429244</PMID>
  </reference>
  <results_reference>
    <citation>Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, Pappas F, Phillips PP, Nunn AJ; REMoxTB Consortium. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med. 2014 Oct 23;371(17):1577-87. doi: 10.1056/NEJMoa1407426. Epub 2014 Sep 7.</citation>
    <PMID>25196020</PMID>
  </results_reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2009</study_first_submitted>
  <study_first_submitted_qc>March 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2009</study_first_posted>
  <results_first_submitted>March 10, 2015</results_first_submitted>
  <results_first_submitted_qc>May 7, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 25, 2015</results_first_posted>
  <last_update_submitted>February 15, 2017</last_update_submitted>
  <last_update_submitted_qc>February 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Moxifloxacin</mesh_term>
    <mesh_term>Fluoroquinolones</mesh_term>
    <mesh_term>Rifampin</mesh_term>
    <mesh_term>Isoniazid</mesh_term>
    <mesh_term>Pyrazinamide</mesh_term>
    <mesh_term>Ethambutol</mesh_term>
    <mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
          <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
        <group group_id="P2">
          <title>Regimen 2 - 2MHRZ/2MHR</title>
          <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
        <group group_id="P3">
          <title>Regimen 3 - 2EMRZ/2MR</title>
          <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Per- Protocol</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="640"/>
                <participants group_id="P2" count="655"/>
                <participants group_id="P3" count="636"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="510"/>
                <participants group_id="P2" count="514"/>
                <participants group_id="P3" count="524"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="130"/>
                <participants group_id="P2" count="141"/>
                <participants group_id="P3" count="112"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Modified Intent to Treat</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="640"/>
                <participants group_id="P2" count="655"/>
                <participants group_id="P3" count="636"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="555"/>
                <participants group_id="P2" count="568"/>
                <participants group_id="P3" count="551"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="85"/>
                <participants group_id="P2" count="87"/>
                <participants group_id="P3" count="85"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Per protocol population</population>
      <group_list>
        <group group_id="B1">
          <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
          <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
        <group group_id="B2">
          <title>Regimen 2 - 2MHRZ/2MHR (Isoniazid)</title>
          <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
        <group group_id="B3">
          <title>Regimen 3 - 2EMRZ/2MR (Ethambutol)</title>
          <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="510"/>
            <count group_id="B2" value="514"/>
            <count group_id="B3" value="524"/>
            <count group_id="B4" value="1548"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 25 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="160"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="146"/>
                    <measurement group_id="B4" value="468"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25-35 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="145"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="175"/>
                    <measurement group_id="B4" value="482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 35 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="205"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="203"/>
                    <measurement group_id="B4" value="598"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="154"/>
                    <measurement group_id="B2" value="163"/>
                    <measurement group_id="B3" value="155"/>
                    <measurement group_id="B4" value="472"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="356"/>
                    <measurement group_id="B2" value="351"/>
                    <measurement group_id="B3" value="369"/>
                    <measurement group_id="B4" value="1076"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="238"/>
                    <measurement group_id="B2" value="210"/>
                    <measurement group_id="B3" value="237"/>
                    <measurement group_id="B4" value="685"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="160"/>
                    <measurement group_id="B2" value="154"/>
                    <measurement group_id="B3" value="161"/>
                    <measurement group_id="B4" value="475"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mixed race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="111"/>
                    <measurement group_id="B2" value="148"/>
                    <measurement group_id="B3" value="126"/>
                    <measurement group_id="B4" value="385"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight group</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 40 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="58"/>
                    <measurement group_id="B4" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40-45 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="90"/>
                    <measurement group_id="B3" value="82"/>
                    <measurement group_id="B4" value="252"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 45-55 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="206"/>
                    <measurement group_id="B2" value="210"/>
                    <measurement group_id="B3" value="204"/>
                    <measurement group_id="B4" value="620"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 55-75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="161"/>
                    <measurement group_id="B2" value="158"/>
                    <measurement group_id="B3" value="174"/>
                    <measurement group_id="B4" value="493"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Never</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="246"/>
                    <measurement group_id="B2" value="231"/>
                    <measurement group_id="B3" value="230"/>
                    <measurement group_id="B4" value="707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Past</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="111"/>
                    <measurement group_id="B3" value="134"/>
                    <measurement group_id="B4" value="364"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Current</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="145"/>
                    <measurement group_id="B2" value="172"/>
                    <measurement group_id="B3" value="160"/>
                    <measurement group_id="B4" value="477"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HIV positivity</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Drug resistance</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Isoniazid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pyrazinamide</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cavitation</title>
          <description>Chest cavitation based on blinded assessment of the chest radiograph.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="368"/>
                    <measurement group_id="B2" value="357"/>
                    <measurement group_id="B3" value="367"/>
                    <measurement group_id="B4" value="1092"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time to positivity on MGIT sputum culture</title>
          <description>Mycobacteria Growth Indicator Tube (MGIT) was used for the detection of mycobacteria.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>≥ 5 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="266"/>
                    <measurement group_id="B2" value="263"/>
                    <measurement group_id="B3" value="258"/>
                    <measurement group_id="B4" value="787"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&lt; 5 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="229"/>
                    <measurement group_id="B2" value="239"/>
                    <measurement group_id="B3" value="254"/>
                    <measurement group_id="B4" value="722"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not available</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Combined Failure of Bacteriological Cure and Relapse Within One Year of Completion of Therapy as Defined by Culture Using Solid Media (Lowenstein-Jensen - LJ).</title>
        <description>The primary efficacy outcome was the proportion of patients who had bacteriologically or clinically defined failure or relapse within 18 months after randomization (a composite unfavorable outcome). Culture-negative status was defined as two negative-culture results at different visits without an intervening positive result. The date of culture-negative status was defined as the date of the first negative-culture result. This status continued until there were two positive cultures, without an intervening negative culture, or until there was a single positive culture that was not followed by two negative cultures. Relapse strains were those shown to be identical on 24-locus Mycobacterial interspersed repetitive units (MIRU) analysis. For the final 18 month study visit when both L-J samples were contaminated or missing, if the subject could not be brought back, liquid medium culture results were used in place of solid medium culture results.</description>
        <time_frame>18 months (within one year of completion of therapy)</time_frame>
        <population>Per protocol population</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Combined Failure of Bacteriological Cure and Relapse Within One Year of Completion of Therapy as Defined by Culture Using Solid Media (Lowenstein-Jensen - LJ).</title>
          <description>The primary efficacy outcome was the proportion of patients who had bacteriologically or clinically defined failure or relapse within 18 months after randomization (a composite unfavorable outcome). Culture-negative status was defined as two negative-culture results at different visits without an intervening positive result. The date of culture-negative status was defined as the date of the first negative-culture result. This status continued until there were two positive cultures, without an intervening negative culture, or until there was a single positive culture that was not followed by two negative cultures. Relapse strains were those shown to be identical on 24-locus Mycobacterial interspersed repetitive units (MIRU) analysis. For the final 18 month study visit when both L-J samples were contaminated or missing, if the subject could not be brought back, liquid medium culture results were used in place of solid medium culture results.</description>
          <population>Per protocol population</population>
          <units>participants with failure or relapse</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="510"/>
                <count group_id="O2" value="514"/>
                <count group_id="O3" value="524"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="78"/>
                    <measurement group_id="O3" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Noninferiority was defined as a between-group difference of less than 6 percentage points in the upper boundary of the two-sided 97.5% Wald confidence interval for the difference in proportion of patients with an unfavorable outcome.</non_inferiority_desc>
            <param_type>Adjusted difference in proportions</param_type>
            <param_value>6.1</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.7</ci_lower_limit>
            <ci_upper_limit>10.5</ci_upper_limit>
            <estimate_desc>Adjusted difference from control in proportion of unfavorable outcome - percentage points</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Noninferiority was defined as a between-group difference of less than 6 percentage points in the upper boundary of the two-sided 97.5% Wald confidence interval for the proportion of patients with an unfavorable outcome.</non_inferiority_desc>
            <param_type>Adjusted difference from control</param_type>
            <param_value>11.4</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>6.7</ci_lower_limit>
            <ci_upper_limit>16.1</ci_upper_limit>
            <estimate_desc>Adjusted difference from control in rate of unfavorable outcome- percentage points</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Grade 3 or 4 Adverse Events (Using a Modified Division of Acquired Immunodeficiency Syndrome National Institute of Allergy and Infectious Diseases [DAIDS] Scale of Adverse Event Reporting)</title>
        <description>The number of participants includes all patients who had at least one grade 3 or 4 adverse event.</description>
        <time_frame>18 months (within one year of completion of therapy)</time_frame>
        <population>Safety population, defined as all subjects who underwent randomization and who received at least on dose of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Grade 3 or 4 Adverse Events (Using a Modified Division of Acquired Immunodeficiency Syndrome National Institute of Allergy and Infectious Diseases [DAIDS] Scale of Adverse Event Reporting)</title>
          <description>The number of participants includes all patients who had at least one grade 3 or 4 adverse event.</description>
          <population>Safety population, defined as all subjects who underwent randomization and who received at least on dose of study drug.</population>
          <units>participants with Grade 3 or 4 AEs</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="639"/>
                <count group_id="O2" value="655"/>
                <count group_id="O3" value="636"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="123"/>
                    <measurement group_id="O2" value="127"/>
                    <measurement group_id="O3" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Combined Failure of Bacteriological Cure and Relapse as Defined by Culture Using Liquid Media (Mycobacteria Growth Indicator Tube-MGIT).</title>
        <description>The secondary analysis of efficacy outcome was the proportion of patients who had bacteriologically or clinically defined failure or relapse within 18 months after randomization (a composite unfavorable outcome) based on MGIT. Culture-negative status was defined as two negative-culture results at different visits without an intervening positive result. The date of culture-negative status was defined as the date of the first negative-culture result. This status continued until there were two positive cultures, without an intervening negative culture, or until there was a single positive culture that was not followed by two negative cultures. Relapse strains were those shown to be identical on 24-locus Mycobacterial interspersed repetitive units (MIRU) analysis.</description>
        <time_frame>18 months (within one year of completion of therapy)</time_frame>
        <population>Per protocol population</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Combined Failure of Bacteriological Cure and Relapse as Defined by Culture Using Liquid Media (Mycobacteria Growth Indicator Tube-MGIT).</title>
          <description>The secondary analysis of efficacy outcome was the proportion of patients who had bacteriologically or clinically defined failure or relapse within 18 months after randomization (a composite unfavorable outcome) based on MGIT. Culture-negative status was defined as two negative-culture results at different visits without an intervening positive result. The date of culture-negative status was defined as the date of the first negative-culture result. This status continued until there were two positive cultures, without an intervening negative culture, or until there was a single positive culture that was not followed by two negative cultures. Relapse strains were those shown to be identical on 24-locus Mycobacterial interspersed repetitive units (MIRU) analysis.</description>
          <population>Per protocol population</population>
          <units>participants with failure or relapse</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="498"/>
                <count group_id="O2" value="498"/>
                <count group_id="O3" value="512"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="98"/>
                    <measurement group_id="O3" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Who Are Culture Negative (Solid LJ Culture)</title>
        <description>Number of patients who are TB LJ culture negative at 8 weeks.</description>
        <time_frame>8 weeks</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Who Are Culture Negative (Solid LJ Culture)</title>
          <description>Number of patients who are TB LJ culture negative at 8 weeks.</description>
          <population>Per protocol</population>
          <units>participants who are culture negative</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="422"/>
                <count group_id="O2" value="457"/>
                <count group_id="O3" value="458"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="352"/>
                    <measurement group_id="O2" value="394"/>
                    <measurement group_id="O3" value="401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Who Are Culture Negative (Liquid MGIT Culture)</title>
        <description>Number of patients who are TB MGIT culture negative at 8 weeks.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Who Are Culture Negative (Liquid MGIT Culture)</title>
          <description>Number of patients who are TB MGIT culture negative at 8 weeks.</description>
          <units>participants who are culture negative</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="419"/>
                <count group_id="O2" value="440"/>
                <count group_id="O3" value="429"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="235"/>
                    <measurement group_id="O2" value="274"/>
                    <measurement group_id="O3" value="260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Culture Negative Sputum Sample (LJ Solid Media)</title>
        <description>Culture negative for TB using LJ cultures.</description>
        <time_frame>18 months</time_frame>
        <population>All randomized patients excluding late screen failures</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Culture Negative Sputum Sample (LJ Solid Media)</title>
          <description>Culture negative for TB using LJ cultures.</description>
          <population>All randomized patients excluding late screen failures</population>
          <units>Time to culture negative status / weeks</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="600"/>
                <count group_id="O2" value="617"/>
                <count group_id="O3" value="604"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" lower_limit="6.0" upper_limit="6.1"/>
                    <measurement group_id="O2" value="6.0" lower_limit="5.1" upper_limit="6"/>
                    <measurement group_id="O3" value="6.0" lower_limit="5.7" upper_limit="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Culture Negative Sputum Sample (MGIT Liquid Media)</title>
        <time_frame>18 months</time_frame>
        <population>All randomized patients excluding late screen failures</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Culture Negative Sputum Sample (MGIT Liquid Media)</title>
          <population>All randomized patients excluding late screen failures</population>
          <units>Time to culture negative status / weeks</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="600"/>
                <count group_id="O2" value="617"/>
                <count group_id="O3" value="604"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.9" lower_limit="8.1" upper_limit="12.0"/>
                    <measurement group_id="O2" value="8.0" lower_limit="8.0" upper_limit="9.9"/>
                    <measurement group_id="O3" value="8.0" lower_limit="8.0" upper_limit="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sensitivity Analysis Assuming All Losses to Follow-up and Non-tuberculous Deaths Have an Unfavorable Outcome Using Solid (L-J) Media.</title>
        <description>Sensitivity Analysis of Primary Efficacy Results of All Randomized Subjects Imputing Unfavorable for Missing Outcomes. Analysis is the number of subjects with an unfavorable outcome. Favorable outcome is defined as the number of subjects with a negative TB culture status at 18 months (at or after 72 weeks), who had not already been classified as having an unfavorable outcome, and whose last positive TB culture result (“isolated positive culture”) was followed by at least two negative culture results.</description>
        <time_frame>18 months</time_frame>
        <population>All randomized subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity Analysis Assuming All Losses to Follow-up and Non-tuberculous Deaths Have an Unfavorable Outcome Using Solid (L-J) Media.</title>
          <description>Sensitivity Analysis of Primary Efficacy Results of All Randomized Subjects Imputing Unfavorable for Missing Outcomes. Analysis is the number of subjects with an unfavorable outcome. Favorable outcome is defined as the number of subjects with a negative TB culture status at 18 months (at or after 72 weeks), who had not already been classified as having an unfavorable outcome, and whose last positive TB culture result (“isolated positive culture”) was followed by at least two negative culture results.</description>
          <population>All randomized subjects.</population>
          <units>participants with unfavorable outcome</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="640"/>
                <count group_id="O2" value="655"/>
                <count group_id="O3" value="636"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172"/>
                    <measurement group_id="O2" value="219"/>
                    <measurement group_id="O3" value="217"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sensitivity Analyses Assuming All Losses to Follow-up and Non-tuberculous Deaths Have a Favourable Outcome Using Solid (L-J) Media.</title>
        <description>Sensitivity Analysis of Primary Efficacy Results of All Randomized Subjects Imputing Favorable for Missing Outcomes. Analysis is the number of subjects with an unfavorable outcome. Favorable outcome is defined as the number of subjects with a negative TB culture status at 18 months (at or after 72 weeks), who had not already been classified as having an unfavorable outcome, and whose last positive TB culture result (“isolated positive culture”) was followed by at least two negative culture results.</description>
        <time_frame>18 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 - 2MHRZ/2MHR</title>
            <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 - 2EMRZ/2MR</title>
            <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity Analyses Assuming All Losses to Follow-up and Non-tuberculous Deaths Have a Favourable Outcome Using Solid (L-J) Media.</title>
          <description>Sensitivity Analysis of Primary Efficacy Results of All Randomized Subjects Imputing Favorable for Missing Outcomes. Analysis is the number of subjects with an unfavorable outcome. Favorable outcome is defined as the number of subjects with a negative TB culture status at 18 months (at or after 72 weeks), who had not already been classified as having an unfavorable outcome, and whose last positive TB culture result (“isolated positive culture”) was followed by at least two negative culture results.</description>
          <units>participants with unfavorable outcome</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="640"/>
                <count group_id="O2" value="655"/>
                <count group_id="O3" value="636"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="132"/>
                    <measurement group_id="O3" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Total Number of SAE events and the number and percentage of subjects experiencing each event by system organ class.</desc>
      <group_list>
        <group group_id="E1">
          <title>Regimen 1 - 2EHRZ/4HR (Control Regimen)</title>
          <description>Eight weeks of chemotherapy with Ethambutol, Isoniazid, Rifampicin and Pyrazinamide plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin plus the Moxifloxacin placebo, followed by
Nine weeks of Isoniazid and Rifampicin only.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
        <group group_id="E2">
          <title>Regimen 2 - 2MHRZ/2MHR</title>
          <description>Eight weeks of chemotherapy with Moxifloxacin, Isoniazid, Rifampicin and Pyrazinamide plus the Ethambutol placebo, followed by
Nine weeks of Moxifloxacin, Isoniazid and Rifampicin, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo.
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
        <group group_id="E3">
          <title>Regimen 3 - 2EMRZ/2MR</title>
          <description>Eight weeks of chemotherapy with Ethambutol, Moxifloxacin, Rifampicin and Pyrazinamide plus the Isoniazid placebo, followed by
Nine weeks of Moxifloxacin and Rifampicin plus the Isoniazid placebo, followed by
Nine weeks of the Isoniazid placebo and the Rifampicin placebo
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide &amp; Rifampicin: Moxifloxacin 400 mg Rifampicin &lt; 45 kg 450 mg &gt; 45 kg 600 mg Isoniazid 300 mg Pyrazinamide &lt; 40 kg 25 mg/kg rounded to nearest 500 mg* 40-55 kg 1000 mg &gt; 55 kg - 75 kg 1500 mg &gt; 75 kg 2000 mg Ethambutol &lt; 40 kg 15 mg/kg rounded to nearest 100 mg 40-55 kg 800 mg &gt; 55 kg - 75 kg 1200 mg &gt; 75 kg 1600 mg *For pyrazinamide dosing in patients &lt; 40 kg, 1000 mg used instead of 500 mg
All treatment is taken daily, for a duration of up to 26 weeks depending on treatment arm.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 16.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="639"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="655"/>
                <counts group_id="E3" subjects_affected="40" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Lower</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Tenderness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Acute Abdomen</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="11" subjects_affected="6" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Diarrhoea Infectious</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Disseminated Tuberculosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Aspartate Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Bilirubin Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Breath Sounds Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gamma- Glutamyltransferase Increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haemoglobin Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hepatic Enzyme Increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Liver Function Test Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Prothrombin Time prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Respiratory Rate Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Weight Decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="6" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="639"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oropharyngeal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="5" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rales</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Respiratory Distress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rhonchi</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 16.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="507" subjects_at_risk="639"/>
                <counts group_id="E2" subjects_affected="537" subjects_at_risk="655"/>
                <counts group_id="E3" subjects_affected="522" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="17" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="16" subjects_affected="13" subjects_at_risk="655"/>
                <counts group_id="E3" events="11" subjects_affected="8" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypochromic Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" events="13" subjects_affected="8" subjects_at_risk="639"/>
                <counts group_id="E2" events="12" subjects_affected="9" subjects_at_risk="655"/>
                <counts group_id="E3" events="12" subjects_affected="9" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lymph Node Pain</sub_title>
                <counts group_id="E1" events="7" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="61" subjects_affected="43" subjects_at_risk="639"/>
                <counts group_id="E2" events="71" subjects_affected="44" subjects_at_risk="655"/>
                <counts group_id="E3" events="68" subjects_affected="50" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Microcytic Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Monocytosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="13" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Neutrophilia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Thrombocytosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Congestive Cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cor Pulmonale</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperdynamic Left Ventricle</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Left Ventricular Hypertrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pericardial Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Sinus Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="54" subjects_affected="40" subjects_at_risk="639"/>
                <counts group_id="E2" events="71" subjects_affected="48" subjects_at_risk="655"/>
                <counts group_id="E3" events="45" subjects_affected="39" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ventricular Hypertrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Auricular Swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cerumen Impaction</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ear Canal Erythema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ear Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ear Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="7" subjects_affected="5" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ear Pruritus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haematotympanum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hearing Impaired</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Otorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tympanic Membrane Hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tympanic Membrane Perforation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tympanic Membrane Scarring</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tympanosclerosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Astigmatism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Conjunctival Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Conjunctival Hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Conjunctival Irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Conjunctival Pallor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Conjunctivitis Allergic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Corneal Opacity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dry Eye</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eye Irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eye Oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eye Pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eye Pruritus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eyelid Oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eyelids Pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypermetropia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lacrimation Increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Night Blindness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ocular Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ocular Hyperaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ocular Icterus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pterygium</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Scleral Hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Scleritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vision Blurred</sub_title>
                <counts group_id="E1" events="12" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="655"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Visual Acuity Reduced</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="639"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="655"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Visual Impairment</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vitreous Floaters</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Distension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="17" subjects_affected="12" subjects_at_risk="639"/>
                <counts group_id="E2" events="20" subjects_affected="15" subjects_at_risk="655"/>
                <counts group_id="E3" events="17" subjects_affected="15" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Lower</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Rigidity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Abdominal Tenderness</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="13" subjects_affected="9" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="6" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Anal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Anal Pruritus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chapped Lips</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="17" subjects_affected="12" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dental Caries</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="9" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="639"/>
                <counts group_id="E2" events="51" subjects_affected="38" subjects_at_risk="655"/>
                <counts group_id="E3" events="59" subjects_affected="46" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Epigastric Discomfort</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Faecal Volume Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Food Poisoning</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Frequent Bowel Movements</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Hypermotility</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Sounds Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gingival Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gingival Recession</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Glossitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperchlorhydria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lip Blister</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lip Swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lip Ulceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lower Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Mouth Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="49" subjects_affected="40" subjects_at_risk="639"/>
                <counts group_id="E2" events="44" subjects_affected="39" subjects_at_risk="655"/>
                <counts group_id="E3" events="50" subjects_affected="45" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oral Mucosal Discolouration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oral Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Paraesthesia Oral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Parotid Gland Enlargement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Post-Tussive Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rectal Discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rectal Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rectal Tenesmus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Salivary Gland Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Salivary Gland Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tongue Coated</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tongue Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tongue Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tongue Ulceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="56" subjects_affected="44" subjects_at_risk="639"/>
                <counts group_id="E2" events="95" subjects_affected="70" subjects_at_risk="655"/>
                <counts group_id="E3" events="92" subjects_affected="70" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adhesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="639"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="655"/>
                <counts group_id="E3" events="19" subjects_affected="16" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Catheter Site Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chest Discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="76" subjects_affected="60" subjects_at_risk="639"/>
                <counts group_id="E2" events="57" subjects_affected="49" subjects_at_risk="655"/>
                <counts group_id="E3" events="68" subjects_affected="55" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Crepitations</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Face Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="12" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="22" subjects_affected="21" subjects_at_risk="655"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gait Disturbance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Generalised Oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Influenza Like Illness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Local Swelling</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Medical Device Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Mucosal Discolouration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" events="22" subjects_affected="20" subjects_at_risk="639"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="655"/>
                <counts group_id="E3" events="30" subjects_affected="23" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="12" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="14" subjects_affected="9" subjects_at_risk="655"/>
                <counts group_id="E3" events="17" subjects_affected="10" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="95" subjects_affected="58" subjects_at_risk="639"/>
                <counts group_id="E2" events="103" subjects_affected="67" subjects_at_risk="655"/>
                <counts group_id="E3" events="116" subjects_affected="84" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tenderness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Thirst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Unevaluable Event</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Xerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic Function Abnormal</sub_title>
                <counts group_id="E1" events="10" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hepatomegaly</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Liver Tenderness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess Neck</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Amoebic Dysentery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Anal Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Body Tinea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Breast Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Bronchitis Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Bronchitis Viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Candida Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chest Wall Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dermatitis Infected</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dysentery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ear Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eye Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Febrile Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Fungal Infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Fungal Skin Infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="14" subjects_affected="13" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Genital Candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Genital Herpes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Giardiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gingival Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Helminthic Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Herpes Zoster</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hiv Infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Impetigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Infected Dermal Cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Infected Skin Ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="639"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="655"/>
                <counts group_id="E3" events="22" subjects_affected="17" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lobar Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lung Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lung Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Malaria</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="639"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="655"/>
                <counts group_id="E3" events="10" subjects_affected="9" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Molluscum Contagiosum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Mycobacterium Fortuitum Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Myringitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="639"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="655"/>
                <counts group_id="E3" events="21" subjects_affected="20" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oesophageal Candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Onychomycosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ophthalmic Herpes Zoster</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oral Candidiasis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="655"/>
                <counts group_id="E3" events="13" subjects_affected="11" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oral Hairy Leukoplakia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oral Herpes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Otitis Externa</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Otitis Media</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Otitis Media Chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pelvic Inflammatory Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pericarditis Tuberculous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="655"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pharyngotonsillitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pneumocystis Jirovecii Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pneumonia Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pneumonia Haemophilus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pulmonary Tuberculosis</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="639"/>
                <counts group_id="E2" events="27" subjects_affected="24" subjects_at_risk="655"/>
                <counts group_id="E3" events="37" subjects_affected="36" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pulpitis Dental</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rash Pustular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection Viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="16" subjects_affected="13" subjects_at_risk="655"/>
                <counts group_id="E3" events="21" subjects_affected="18" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Schistosomiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Schistosomiasis Bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Septic Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Subcutaneous Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tinea Capitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tinea Faciei</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tinea Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tinea Pedis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tinea Versicolour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tooth Abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tooth Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="655"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tuberculosis Gastrointestinal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Typhoid Fever</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="27" subjects_affected="24" subjects_at_risk="639"/>
                <counts group_id="E2" events="23" subjects_affected="20" subjects_at_risk="655"/>
                <counts group_id="E3" events="24" subjects_affected="20" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="639"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="655"/>
                <counts group_id="E3" events="12" subjects_affected="11" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vaginitis Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Viral Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Viral Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="13" subjects_affected="7" subjects_at_risk="639"/>
                <counts group_id="E2" events="11" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="11" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Candidiasis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="6" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vulvovaginitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Wound Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Animal Bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eyelid Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Fibula Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Foreign Body</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Foreign Body In Eye</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hand Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Human Bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Incorrect Dose Administered</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Injury Corneal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Jaw Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Joint Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ligament Sprain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lip Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Muscle Strain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Periorbital Contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Road Traffic Accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Scar</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skeletal Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Soft Tissue Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Stab Wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Subdural Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Thermal Burn</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tibia Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tooth Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Activated Partial Thromboplastin Time Prolonged</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="13" subjects_affected="10" subjects_at_risk="655"/>
                <counts group_id="E3" events="16" subjects_affected="13" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferase Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferase Decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="37" subjects_affected="25" subjects_at_risk="639"/>
                <counts group_id="E2" events="39" subjects_affected="30" subjects_at_risk="655"/>
                <counts group_id="E3" events="24" subjects_affected="16" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Amylase Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Aspartate Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="41" subjects_affected="28" subjects_at_risk="639"/>
                <counts group_id="E2" events="47" subjects_affected="35" subjects_at_risk="655"/>
                <counts group_id="E3" events="31" subjects_affected="24" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Albumin Decreased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Bilirubin Increased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="14" subjects_affected="9" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Creatine Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="639"/>
                <counts group_id="E2" events="17" subjects_affected="15" subjects_at_risk="655"/>
                <counts group_id="E3" events="10" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Glucose Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Glucose Increased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="9" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Potassium Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Potassium Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Pressure Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Pressure Diastolic Decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Pressure Diastolic Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Pressure Increased</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Pressure Systolic Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Pressure Systolic Increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Sodium Decreased</sub_title>
                <counts group_id="E1" events="9" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Sodium Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Urea Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blood Uric Acid Increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Body Temperature Increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Breath Sounds Abnormal</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="639"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cardiac Murmur</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cd4 Lymphocytes Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chest X-Ray Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Coagulation Test Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Colour Vision Tests Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Creatinine Renal Clearance Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gamma-Glutamyltransferase Increased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Examination Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Glucose Urine Present</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haemoglobin Decreased</sub_title>
                <counts group_id="E1" events="24" subjects_affected="13" subjects_at_risk="639"/>
                <counts group_id="E2" events="29" subjects_affected="18" subjects_at_risk="655"/>
                <counts group_id="E3" events="28" subjects_affected="20" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Heart Rate Increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Heart Rate Irregular</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Heart Sounds Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hepatic Enzyme Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hepatic Enzyme Increased</sub_title>
                <counts group_id="E1" events="36" subjects_affected="22" subjects_at_risk="639"/>
                <counts group_id="E2" events="30" subjects_affected="18" subjects_at_risk="655"/>
                <counts group_id="E3" events="17" subjects_affected="11" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Liver Function Test Abnormal</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Liver Palpable Subcostal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lymph Node Palpable</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Neutrophil Count Decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Neutrophil Percentage Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ophthalmological Examination Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Percussion Test Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Platelet Count Decreased</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Prothrombin Level Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Prothrombin Time Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Prothrombin Time Prolonged</sub_title>
                <counts group_id="E1" events="15" subjects_affected="11" subjects_at_risk="639"/>
                <counts group_id="E2" events="16" subjects_affected="13" subjects_at_risk="655"/>
                <counts group_id="E3" events="30" subjects_affected="20" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pulmonary Physical Examination Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Red Blood Cell Sedimentation Rate Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Respiratory Rate Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Transaminases Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Urine Analysis Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Urine Cytology Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Urine Leukocyte Esterase Positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Weight Decreased</sub_title>
                <counts group_id="E1" events="83" subjects_affected="62" subjects_at_risk="639"/>
                <counts group_id="E2" events="85" subjects_affected="70" subjects_at_risk="655"/>
                <counts group_id="E3" events="77" subjects_affected="72" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Decreased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal Loss Of Weight</sub_title>
                <counts group_id="E1" events="22" subjects_affected="15" subjects_at_risk="639"/>
                <counts group_id="E2" events="23" subjects_affected="20" subjects_at_risk="655"/>
                <counts group_id="E3" events="18" subjects_affected="16" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Decreased Appetite</sub_title>
                <counts group_id="E1" events="54" subjects_affected="45" subjects_at_risk="639"/>
                <counts group_id="E2" events="35" subjects_affected="33" subjects_at_risk="655"/>
                <counts group_id="E3" events="50" subjects_affected="45" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="10" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="655"/>
                <counts group_id="E3" events="13" subjects_affected="9" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus Inadequate Control</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Iron Deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vitamin B Complex Deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="182" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="177" subjects_affected="12" subjects_at_risk="655"/>
                <counts group_id="E3" events="162" subjects_affected="10" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="12" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Arthrotoxicity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="7" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" events="26" subjects_affected="19" subjects_at_risk="639"/>
                <counts group_id="E2" events="24" subjects_affected="20" subjects_at_risk="655"/>
                <counts group_id="E3" events="22" subjects_affected="20" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chondrotoxicity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Clubbing</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Finger Deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Flank Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Gouty Arthritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Joint Range Of Motion Decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Joint Stiffness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Joint Swelling</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="9" subjects_affected="6" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ligament Pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Metatarsalgia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Muscle Atrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Muscle Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Muscle Spasms</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="639"/>
                <counts group_id="E2" events="10" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Muscle Swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" events="17" subjects_affected="12" subjects_at_risk="639"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Stiffness</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="639"/>
                <counts group_id="E2" events="41" subjects_affected="28" subjects_at_risk="655"/>
                <counts group_id="E3" events="25" subjects_affected="21" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pain In Extremity</sub_title>
                <counts group_id="E1" events="44" subjects_affected="32" subjects_at_risk="639"/>
                <counts group_id="E2" events="38" subjects_affected="27" subjects_at_risk="655"/>
                <counts group_id="E3" events="43" subjects_affected="29" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Sensation Of Heaviness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Spinal Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Synovial Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tendon Disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tendon Pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Trigger Finger</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Upper Extremity Mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Anogenital Warts</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Penile Wart</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pharyngeal Neoplasm Benign</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Thyroid Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Ageusia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Burning Sensation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="639"/>
                <counts group_id="E2" events="25" subjects_affected="16" subjects_at_risk="655"/>
                <counts group_id="E3" events="32" subjects_affected="26" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dizziness Postural</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="44" subjects_affected="35" subjects_at_risk="639"/>
                <counts group_id="E2" events="45" subjects_affected="39" subjects_at_risk="655"/>
                <counts group_id="E3" events="63" subjects_affected="52" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hemiplegia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperreflexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="14" subjects_affected="8" subjects_at_risk="639"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="655"/>
                <counts group_id="E3" events="19" subjects_affected="12" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Loss Of Consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Memory Impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Neuritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Neuropathy Peripheral</sub_title>
                <counts group_id="E1" events="16" subjects_affected="13" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="14" subjects_affected="11" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="8" subjects_at_risk="639"/>
                <counts group_id="E2" events="13" subjects_affected="10" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Parosmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Post Herpetic Neuralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Restless Legs Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Sensory Disturbance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tension Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Visual Field Defect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion Threatened</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pregnancy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Anxiety Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Initial Insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="16" subjects_affected="12" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nervousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Premature Ejaculation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Psychotic Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Sleep Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bilirubinuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Enuresis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Glycosuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Leukocyturia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Renal Colic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Urethral Discharge</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast Discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Breast Pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Erectile Dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Fibrocystic Breast Disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Genital Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Genital Ulceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Menometrorrhagia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Menstruation Irregular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nipple Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Penile Discharge</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Polymenorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pruritus Genital</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Testicular Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vaginal Discharge</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vaginal Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vaginal Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="107" subjects_affected="85" subjects_at_risk="639"/>
                <counts group_id="E2" events="136" subjects_affected="11" subjects_at_risk="655"/>
                <counts group_id="E3" events="188" subjects_affected="13" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="70" subjects_affected="49" subjects_at_risk="639"/>
                <counts group_id="E2" events="67" subjects_affected="54" subjects_at_risk="655"/>
                <counts group_id="E3" events="99" subjects_affected="79" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dyspnoea Exertional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="59" subjects_affected="51" subjects_at_risk="639"/>
                <counts group_id="E2" events="71" subjects_affected="55" subjects_at_risk="655"/>
                <counts group_id="E3" events="47" subjects_affected="40" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="655"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Mediastinal Shift</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nasal Congestion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nasal Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nasal Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nasal Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Nasal Ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Obstructive Airways Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Oropharyngeal Pain</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="639"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="655"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pharyngeal Erythema</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pharyngeal Oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pleural Rub</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pleuritic Pain</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="19" subjects_affected="18" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Productive Cough</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pulmonary Arterial Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pulmonary Congestion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pulmonary Hilum Mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rales</sub_title>
                <counts group_id="E1" events="17" subjects_affected="11" subjects_at_risk="639"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="655"/>
                <counts group_id="E3" events="20" subjects_affected="18" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Respiratory Disorder</sub_title>
                <counts group_id="E1" events="58" subjects_affected="46" subjects_at_risk="639"/>
                <counts group_id="E2" events="63" subjects_affected="52" subjects_at_risk="655"/>
                <counts group_id="E3" events="69" subjects_affected="54" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Respiratory Fremitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rhinitis Allergic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="639"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rhonchi</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Throat Irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tonsillar Hypertrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tonsillar Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Upper-Airway Cough Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="10" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="655"/>
                <counts group_id="E3" events="11" subjects_affected="9" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Chloasma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dermal Cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dermatitis Acneiform</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dermatitis Allergic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dermatitis Bullous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dermatitis Contact</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Diabetic Foot</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Dry Skin</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Exfoliative Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hand Dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hyperkeratosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Intertrigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Milia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Miliaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Night Sweats</sub_title>
                <counts group_id="E1" events="32" subjects_affected="29" subjects_at_risk="639"/>
                <counts group_id="E2" events="50" subjects_affected="48" subjects_at_risk="655"/>
                <counts group_id="E3" events="61" subjects_affected="57" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pemphigus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="46" subjects_affected="39" subjects_at_risk="639"/>
                <counts group_id="E2" events="52" subjects_affected="35" subjects_at_risk="655"/>
                <counts group_id="E3" events="47" subjects_affected="37" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pruritus Generalised</sub_title>
                <counts group_id="E1" events="22" subjects_affected="18" subjects_at_risk="639"/>
                <counts group_id="E2" events="20" subjects_affected="16" subjects_at_risk="655"/>
                <counts group_id="E3" events="12" subjects_affected="9" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="33" subjects_affected="25" subjects_at_risk="639"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="655"/>
                <counts group_id="E3" events="32" subjects_affected="22" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rash Generalised</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rash Macular</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="639"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rash Maculo-Papular</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rash Maculovesicular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rash Papular</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="639"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="655"/>
                <counts group_id="E3" events="13" subjects_affected="8" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Rash Pruritic</sub_title>
                <counts group_id="E1" events="12" subjects_affected="9" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="8" subjects_affected="5" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Seborrhoeic Dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skin Discolouration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skin Exfoliation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skin Hyperpigmentation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skin Hypopigmentation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skin Lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skin Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Skin Warm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Swelling Face</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Cosmetic Body Piercing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Physical Assault</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Victim Of Crime</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cataract Operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Ear Operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Eye Prosthesis Insertion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Finger Amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Leg Amputation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Tooth Extraction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Diastolic Hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hot Flush</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="28" subjects_affected="15" subjects_at_risk="639"/>
                <counts group_id="E2" events="30" subjects_affected="18" subjects_at_risk="655"/>
                <counts group_id="E3" events="16" subjects_affected="10" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Pallor</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="639"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Poor Peripheral Circulation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Systolic Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
              <event>
                <sub_title>Varicose Vein</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="639"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="655"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="636"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Daniel E. Everitt, MD, Vice President and Senior Medical Officer</name_or_title>
      <organization>Global Alliance for TB Drug Development</organization>
      <phone>(212) 227-7540</phone>
      <email>Dan.Everitt@tballiance.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

